Aging is a process accompanied by progressive decline in cellular function. Our aim is to create a groundbreaking therapy based on patented proteins, that rejuvenate elderly cells, all while maintaining their distinct properties.
Our technology was developed based on extensive scientific research published in prestigious, high-impact journals from the Nature, Science, and Cell publishing groups.
Ananda Labs Inc. is at the forefront of epigenetic reprogramming for longevity and anti-aging, developed in partnership with the Hebrew University of Jerusalem.
Ananda Labs is creating advanced therapeutics centered on epigenetic reprogramming to combat human diseases and promote anti-aging.
This involves altering gene expression without changing the DNA sequence, using epigenetic editors—a potentially revolutionary advancement in the medical and wellness industry.
Ananda Labs has a superior and safer set of patented factors compared to competitors, providing a significant advantage. Competitors’ valuations range from hundreds of millions to a few billion dollars, all being in the R&D stage.
Onassis and Ananda Labs hold exclusive licensing rights to several key patents, including the method for reprogramming human cells.
We aim to rejuvenate fibroblast cells by 40%-50% of their age to provide long-lasting skin elasticity and a healthy, younger appearance. Our research will focus on:
Short term goal
Long term goal
Request password by email: info@ananda-labs.com